Breadcrumb Home Studies Studies Search Filter Research Area All Brain and Mental Health Cure and Immunotherapy Therapeutics Tuberculosis Study Status All Closed to Accrual Closed to Follow Up Concluded Enrolling In Development Participants Off Study and Primary Analysis Completed Pending Sort Study Number Asc Study Number Desc Submit Search Showing 13 studies. P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed P1100: AERAS 402 DAIDS Number 11801 Research Area Tuberculosis Study Status Concluded P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed Pagination Previous page Prev Page 1 Current page 2
P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed
P1078: TB APPRISE: TB Ante vs. Postpartum Prevention with INH in HIV Seropositive mothers and their Exposed infants DAIDS Number 10732 Research Area Tuberculosis Study Status Participants Off Study and Primary Analysis Completed